Discover the Cipla Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Friday, as the industry braces ...

We would like most of the manufacturing to be centric in locations where it is most economic. Looking at every country's ...

Shares of Cipla are set to be in focus on Friday after the company received final approval from the U.S. Food and Drug Administration for its New Drug Application (NDA) for Nilotinib capsules ...

Nomura has a Buy rating on Cipla after the company's MD reassured that the competitiveness of the Indian generics biz won't ...

Stay informed with the Cipla Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

India, often dubbed the "pharmacy of the world", is among the top exporters to the U.S., especially for cheaper versions of ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Structure: Impulse within a larger degree Corrective Structure. Position: Minor Wave 3 Grey. Additionally, Minor Wave 3 is subdividing into five waves at a Minute Degree: Minute Wave (i ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

For Monday, an analyst from a domestic brokerage assigned 'Buy/Sell' calls on Kfin Technologies, MOFSL and Cipla shares.

MUMBAI/BENGALURU, Feb 28 (Reuters) - Tariffs should not influence decisions at Indian drug companies, Cipla's (CIPL.NS), opens new tab top executive said on Friday, as the industry braces for U.S ...